Abstract:Background Radiotherapy is one of the most important therapeutic strategies for treating cancer. For decades, studies concerning the outcomes of radiotherapy mainly focused on the biological effects of radiation on tumor cells. Recently, we have increasingly recognized that the complex cellular interactions within the tumor microenvironment (TME) are closely related to treatment outcomes. Main content As a critical component of the TME, fibroblasts participate in all stages of cancer progression. Fibroblasts are able to tolerate harsh extracellular environments, which are usually fatal to all other cells. They play pivotal roles in determining the treatment response to chemoradiotherapy. Radiotherapy activates the TME networks by inducing cycling hypoxia, modulating immune reaction, and promoting vascular regeneration, inflammation and fibrosis. While a number of studies claim that radiotherapy affects fibroblasts negatively through growth arrest and cell senescence, others argue that exposure to radiation can induce an activated phenotype in fibroblasts. These cells take an active part in constructing the tumor microenvironment by secreting cytokines and degradative enzymes. Current strategies that aim to inhibit activated fibroblasts mainly focus on four aspects: elimination, normalization, paracrine signaling blockade and extracellular matrix inhibition. This review will describe the direct cellular effects of radiotherapy on fibroblasts and the underlying genetic changes. We will also discuss the impact of fibroblasts on cancer cells during radiotherapy and the potential value of targeting fibroblasts to enhance the clinical outcome of radiotherapy. Conclusion This review provides good preliminary data to elucidate the biological roles of CAFs in radiotherapy and the clinical value of targeting CAFs as a supplementary treatment to conventional radiotherapy. Further studies to validate this strategy in more physiological models may be required before clinical trial.

Research progress in the role of cancer-associated fibroblasts in colorectal cancer and related therapies

The Diverse Functions and Therapeutic Implications of Cancer-Associated Fibroblasts in Colorectal Cancer

Cancer‐associated Fibroblasts in Breast Cancer: Challenges and Opportunities

Role of cancer-associated fibroblasts in colorectal cancer and their potential as therapeutic targets

Cancer-Associated Fibroblasts Suppress Cancer Development: The Other Side of the Coin

Research progress of tumor-associated fibroblast in immunosuppression of lung cancer

[Progress on Cancer Associated Fibroblasts in Tumor Immunoregulation].

The Versatile Roles of Cancer-Associated Fibroblasts in Colorectal Cancer and Therapeutic Implications

Targeting the Devil: Strategies Against Cancer-Associated Fibroblasts in Colorectal Cancer.

Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities

The recent advances of cancer associated fibroblasts in cancer progression and therapy

Cancer Associated Fibroblasts: an Essential Role in the Tumor Microenvironment

Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials

Recent advances in cancer-associated fibroblast: Biomarkers, signaling pathways, and therapeutic opportunities

The role of cancer-associated fibroblasts in the invasion and metastasis of colorectal cancer

Cancer Associated Fibroblasts Tailored Tumor Microenvironment of Therapy Resistance in Gastrointestinal Cancers

Unraveling the role of cancer-associated fibroblasts in colorectal cancer

Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures

The importance of cancer-associated fibroblasts in targeted therapies and drug resistance in breast cancer

The Impact of Cancer-Associated Fibroblasts on the Biology and Progression of Colorectal Carcinomas

Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives